Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.65 +0.02 (+1.23%)
As of: Sep 30, 2026 · 3:51 PM EDT

Transcode Therapeutics (RNAZ) Operating Expenses (2020 - 2026)

Updated

Transcode Therapeutics' Operating Expenses came in at $6.79 million for Q2 2026, up 60.8% from $4.22 million a year earlier but down 61.8% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Operating Expenses (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Transcode Therapeutics reported Operating Expenses of $45.13 million, up 208.1% year-over-year; for FY2025, it was $27.98 million, up 78.7% from FY2024.

  • Operating Expenses carries a five-year compound annual growth rate of 107.5% (FY2020 to FY2025).
  • Going back by year, Operating Expenses was $15.66 million in FY2024 (-19.4%), $19.42 million in FY2023 (+4.2%), $18.63 million in FY2022 (+202.9%) and $6.15 million in FY2021 (+746.6%).
  • The five-year range for quarterly Operating Expenses is $2.17 million (Q3 2024) to $17.76 million (Q1 2026).
  • Year-over-year, Operating Expenses has increased for four consecutive quarters, with growth averaging 98.8% over the last eight quarters.
  • The fastest year-over-year change in Operating Expenses over five years came in Q3 2021 (growth of 885.4%), and the weakest in Q3 2024 (a decline of 59.2%).
  • Business Quant data shows RNAZ's Operating Expenses at $17.76 million (Q1 2026), $16.03 million (Q4 2025) and $4.56 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 10.12 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 10.56 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -9.70 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.09 Bn
10 Transcode Therapeutics 1.65 Mn 1.65 Mn - 6.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.79 Mn
Mar 31, 2026 17.76 Mn
Dec 31, 2025 16.03 Mn
Sep 30, 2025 4.56 Mn
Jun 30, 2025 4.22 Mn
Mar 31, 2025 3.17 Mn
Dec 31, 2024 5.09 Mn
Sep 30, 2024 2.17 Mn
Jun 30, 2024 5.11 Mn
Mar 31, 2024 3.29 Mn
Dec 31, 2023 4.10 Mn
Sep 30, 2023 5.31 Mn
Jun 30, 2023 5.12 Mn
Mar 31, 2023 4.89 Mn
Dec 31, 2022 5.50 Mn
Sep 30, 2022 4.95 Mn
Jun 30, 2022 4.71 Mn
Mar 31, 2022 3.48 Mn
Dec 31, 2021 2.99 Mn
Sep 30, 2021 2.36 Mn
API Access

Transcode Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=RNAZ&period=max&api_key=YOUR_API_KEY